AI in cancer pathology
Deep learning on digital pathology slides.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 52, 58, 103, 107, 162.
New guidelines and consensus this year
- [Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2026 edition)]Zhonghua Zhong Liu Za Zhi2026 Sep 23
- [Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2026 edition)]Zhonghua Yi Xue Za Zhi2026 Sep 22
- Expected Values of Artificial Intelligence in Colon Capsule Endoscopy: Artificial Intelligence in Capsule Endoscopy Consortium Position StatementEndosc Int Open2026
All papers from the last 12 months
1,795 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Association of AI-derived abdominal organ volumetry with postoperative outcomes in clear cell renal cell carcinoma: a multicentre studyAnn Med2026 DecPMID 42723375
- Bibliometric analysis of 50 years of publications in Skeletal Radiology (1976-2025): trends, impact, and global collaboration patternsSkeletal Radiol2026 DecPMID 42696170
- Deciphering tissue architecture with StKAN: A multi-modal deep learning framework combining morphology and spatial transcriptomicsComput Biol Chem2026 DecPMID 42641426
- Present status of prostate cancer diagnosis, limitations, challenges, and future endeavorsAnn Med2026 DecPMID 42544420Review
- Artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis of the landscapeHum Vaccin Immunother2026 DecPMID 42518298
- Multimodal deep learning for predicting WHO/ISUP grading in renal tumors on CT using a self-attention-based model: variable Vision Transformer (vViT)Eur J Radiol Open2026 DecPMID 42436714
- On the current clinical applicability of artificial intelligence in pathology: An evidence-informed clinical readiness reviewAnn Diagn Pathol2026 DecPMID 42424941Review
- An automatic detection model for spread through air spaces in postoperative pathological sections based on deep learning in NSCLCComput Assist Surg (Abingdon)2026 DecPMID 42172197
- A data fusion deep learning approach for accurate organelle-based classification of cancer cellsHealth Inf Sci Syst2026 DecPMID 41659840
- Artificial intelligence-assisted real-time nasopharyngeal cancer diagnostic model enhances rhinologist performance: a prospective multi-reader studyAnn Med2026 DecPMID 41630445
More oncology trends
All specialties →Perioperative immunotherapy
Immune checkpoint inhibitors given before and after cancer surgery.
Bispecific antibodies in solid tumours
Bispecific antibodies such as tarlatamab, amivantamab and ivonescimab.
Personalised cancer vaccines
mRNA and neoantigen vaccines tailored to a patient's tumour.
Cell therapy in solid tumours
CAR-T, TIL and TCR-T therapies for solid tumours.
CDK4/6 inhibitors in breast cancer
Palbociclib, ribociclib and abemaciclib in hormone receptor-positive breast cancer.
Radioligand therapy
Radioactive drugs that target tumour receptors, such as lutetium-177 PSMA.
Key point: Most international guidelines endorse 177Lu-PSMA-617 for PSMA-positive metastatic castration-resistant prostate cancer after prior ARPI and taxane chemotherapy.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
("artificial intelligence"[tiab] OR "deep learning"[tiab]) AND (pathology[tiab] OR "whole slide"[tiab] OR histopatholog*[tiab]) AND (cancer[tiab] OR tumor*[tiab] OR tumour*[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.